Search Results 1701-1710 of 21439 for platelets

1. A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

   ... platelet count, international normalized ratio (INR) and total bilirubin 7. History of liver transplantation. Note: Other protocol defined Inclusion ...

2. A Study to Compare Marrow Venting Procedure Versus PRP - Mayo Clinic

   The primary objective of this study is to compare post-operative patient reported outcome measures of Bone Marrow Venting Procedure (BMVP) versus Platelet Rich ...

3. A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy - Mayo Clinic

   Subjects with bleeding disorders and/or impaired platelet function, or neutropenia. Subjects with a prior history of renal, liver or cardiac insufficiency ...

4. A Study to Evaluate the Long-Term Effectiveness, Safety, and Tolerability of Repeated Administration of ABT-494 in Patients with Crohn's Disease - Mayo Clinic

   Platelet count < 50,000/μL;; Absolute lymphocytes count < 500/μL;; Hemoglobin < 8 gm/dL. Subject is not in compliance with prior and concomitant medication ...

5. Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients - Mayo Clinic

   Platelet count < 100,000/ul within 24 hours prior to randomization; Acute infectious process: acute bacterial, fungal, or viral disease OR acute exacerbation ...

6. Sports Medicine - Doctors - Mayo Clinic

   Physiatrist. Areas of focus: Platelet rich plasma injection, Ultrasound-guided injection, Osteoarthritis, Sports injury, Tendon pain, Tendinopathy ...

7. Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM) - Mayo Clinic

   ECOG performance status of 0-1. 9. Platelet count >50,000/mm3 (correctable allowed) within 30 days prior to study treatment. Exclusion Criteria: 1. Patient ...

8. Infections and Other Complications of Cirrhosis - Mayo Clinic

   Cirrhosis as diagnosed by either liver histology or a combination of clinical, biochemical (low platelets, elevated bilirubin and/or INR, low albumin) ...

9. Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors - Mayo Clinic

   ... platelets ≥100,000/mm3; Adequate renal function: serum creatinine <1.5 x ULN or calculated CrCl >60 mL/min using Cockcroft-Gault formula; Adequate hepatic ...

10. Study To Evaluate The Efficacy And Safety Of Elafibranor In Patients With Primary Biliary Cholangitis (PBC) And Inadequate Response To Ursodeoxycholic Acid - Mayo Clinic

    Platelet count <150 X 10 3/microliter; Albumin <3.5 g/dL; Presence of clinical complications of PBC or clinically significant hepatic decompensation ...